BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Sildenafil Citrate

A PHOSPHODIESTERASE TYPE-5 INHIBITOR; VASODILATOR AGENT and UROLOGICAL AGENT that is used in the treatment of ERECTILE DYSFUNCTION and PRIMARY PULMONARY HYPERTENSION.

300+ PubMed studies analyzed · 25 RCTs · Evidence Score: 46.7

Research Domains

Sildenafil Citrate has been studied across 20 research domains including ♀♂ Sexual Health, ❤️ Cardiovascular, 🔬 Oncology, 🫁 Respiratory, 🔥 Metabolic. The primary research focus is ♀♂ Sexual Health with 32% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Sildenafil Citrate, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Dimethisterone
10 shared targets
Betamethasone
10 shared targets
Dexamethasone
7 shared targets
Itraconazole
9 shared targets
Methylprednisolone
8 shared targets
Fluorometholone
9 shared targets
Secologanin
8 shared targets
Norethindrone
11 shared targets
Dydrogesterone
8 shared targets
Polidocanol
10 shared targets
Loading evidence profile...

This evidence profile for Sildenafil Citrate is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.